# 5067-1548). Next adapters were ligated to the RNA fragments' 3′ end using T4 RNA Ligase 2 Deletion mutant (Epicentre, Madison, WI, USA Cat # LR2D1132K) followed by ligating RNA adapters to the 5′ end of each fragment. cDNA synthesis was performed on miRNA using SuperScript II reverse transcriptase (Invitrogen, Carlsbad, CA, USA Cat # 18064-014). Resulting adapterligated cDNA was amplified using 11 cycles of PCR. Pregel assessment of cDNA done using Bioanalyzer High Sensitivity DNA Kit (Agilent Technologies, Santa Clara, CA, USA Cat # 5067-4626) to ensure the small RNA 140-160nt peak was present. Entire sample containing the amplified cDNA construct ran on 6% polyacrylamide gel for 60 min at 145V. Gel stained with 10000X SYBR Gold (Lifetech, Carlsbad, CA, USA Cat # S-11494) and visualized on transilluminator. Gel slice containing the 147 nt and 157 nt bands removed, DNA was eluted overnight and then filtered through a 5 µm filter tube. 
RNA sequencing
Libraries were prepared using the TruSeq Stranded mRNA Sample Prep Kit (Illumina, Cat # RS-122-2101). In brief, polyA containing mRNA molecules were purified from 4 ug of total RNA (RIN > 7) using poly-T oligos attached to magnetic beads. mRNA was then fragmented to approximately 300 bp during the polyA elution step. First strand cDNA synthesis was performed using SuperScript II reverse transcriptase (Invitrogen, Cat # 18064-014) and random primers. Removing the RNA template and synthesizing the replacement strand, incorporating dUTP in place of dTTP, prepared double stranded cDNA, which was then used as template for library preparation. cDNA was then 3′end adenylated followed by ligation of the indexing adapters. Adapterligated DNA was enriched using 15 cycles of PCR. All purification and size selection steps were performed using AMPure XP SPRI beads (Beckman Coulter Genomics, Danvers, MA, USA Cat # A63881). Libraries were validated using the Agilent Bioanalyzer High Sensitivity DNA Kit (Agilent Technologies, Santa Clara, CA, USA Cat 
Bioinformatical analysis of NGS data RNA sequencing
Paired end reads were trimmed to 75 bp to remove low quality sequence prior to alignment. Reads were aligned to the UCSC hg19 reference genome using tophat (v2.0.3), followed by transcript assembly and estimation of expression levels (fpkm) with cufflinks (v2.0.2). Reads from xenograft samples were first filtered to removed unambiguous mouse sequence using xenome(v1.0.1).
Supplementary Figure 1: Effect of different sunitinib concentration on apoptosis evaluated by AnnexinV & PropidiumIodide flow cytometry.
Differential expression between groups was determined using the cuffdiff module of cufflinks, providing fold change estimates, associated p-values and q-values. The cufdiff output was reviewed with the R package cummeRbund, to generate a variety of visualizations of the data and summaries of the most significant differently expressed events.
MiRNA sequencing
Reads were aligned to a database of mature RNA sequences (mirBase 20) using novoalign v2.08.02. The first 12 bases of the Illumina adapter (TGGAATTCTCGG) were supplied to novoalign for adapter trimming. The number of reads uniquely mapping to each mature RNA sequence were counted. Raw counts were normalized and transformed using the R package EdgeR and the voom transformation from the R package limma. Differential expression between groups was determined using the limma package.
Supplementary Figure 2:
Cluster analysis and number of differentially expressed genes between control, sensitive and resistant tumors based on mRNA analysis (A-B) and miRNA profiling (C-D). miRNA-target network analysis (E) comparing sunitinib-sensitive and resistant tumors. Each node (circle) represents a gene/miRNA, the connected lines represent interactions between molecules. HUBs are defined as the top 10% of the nodes with highest number of interaction. The analysis shows central involvement of miR-1/MDGA1 interactions (highlighted on the right in the rectangle). 
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